image
Regeneron Pharmaceuticals, Inc. REGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 585.315
-0.297 %
$ 62.6 B
Market Cap
14.64
P/E
Price Target Average
95.46%
Revenue Forecast Estimate
7.77%
EBIT Estimate
18.70%
Net Income Estimate
14.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Regeneron Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for REGN of $1.14 K, with forecasts ranging from a low of $805 to a high of $1.3 K.
REGN Lowest Price Target Wall Street Target
805 USD 37.53%
REGN Average Price Target Wall Street Target
1.14 K USD 95.46%
REGN Highest Price Target Wall Street Target
1.3 K USD 122.10%
Price
Max Price Target
Min Price Target
Average Price Target
1k1k1k1k1k1k1k1k900900800800700700600600500500Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart REGN

image
$20.0b$20.0b$18.0b$18.0b$16.0b$16.0b$14.0b$14.0b$12.0b$12.0b$10.0b$10.0b$8.0b$8.0b$6.0b$6.0b$4.0b$4.0b$2.0b$2.0b$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart REGN

image
$9.0b$9.0b$8.0b$8.0b$7.0b$7.0b$6.0b$6.0b$5.0b$5.0b$4.0b$4.0b$3.0b$3.0b$2.0b$2.0b$1.0b$1.0b$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart REGN

image
$9.0b$9.0b$8.0b$8.0b$7.0b$7.0b$6.0b$6.0b$5.0b$5.0b$4.0b$4.0b$3.0b$3.0b$2.0b$2.0b$1.0b$1.0b$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029